A detailed history of Strategic Blueprint, LLC transactions in Cybin Inc. stock. As of the latest transaction made, Strategic Blueprint, LLC holds 38,000 shares of CYBN stock, worth $9,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,000
Previous 32,000 18.75%
Holding current value
$9,880
Previous $13,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$0.3 - $0.46 $1,800 - $2,760
6,000 Added 18.75%
38,000 $15,000
Q2 2022

Aug 12, 2022

BUY
$0.41 - $0.88 $4,920 - $10,560
12,000 Added 60.0%
32,000 $18,000
Q4 2021

Feb 14, 2022

BUY
$1.13 - $2.31 $22,599 - $46,200
20,000 New
20,000 $24,000

Others Institutions Holding CYBN

About CYBIN INC.


  • Ticker CYBN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 166,120,000
  • Market Cap $43.2M
  • Description
  • Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...
More about CYBN
Track This Portfolio

Track Strategic Blueprint, LLC Portfolio

Follow Strategic Blueprint, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Blueprint, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Blueprint, LLC with notifications on news.